Companion Animal Arthritis Market (By Animal Type: Dogs, Cats; By Indication; By Treatment; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

The global companion animal arthritis market was surpassed at USD 2.96 billion in 2021 and is expected to hit around USD 5.3 billion by 2030, growing at a CAGR of 6.69% from 2022 to 2030.

Report Highlights

• The dogs' segment dominated the global market with a share of over 60.04% in 2021.
• The cats' segment is anticipated to expand at a CAGR of 7.48% during the forecast period.
• The osteoarthritis segment dominated the market in 2021 with a revenue share of over 75.06%. 
• The medication segment held the largest revenue share of over 55.05% in 2021. 
• The veterinary hospitals and clinics segment held the largest revenue share of 30.04% in 2021. 
• North America held the largest revenue share of more than 30.1% in 2021.
• The European region held the second-largest revenue share in 2021. 
• The Asia Pacific region is estimated to expand at a CAGR of 8.33% in the forecast period.
• By animal type, the North America companion animal arthritis market was valued at USD 1.3 billion in 2021 and expected to witness growth at a CAGR of 6.5% from 2022 to 2030.

The key drivers for the market are the increasing prevalence of osteoarthritis in companion animals due to their longer life duration and the vulnerability of older pets to get degenerative joint diseases owing to their cartilage weakness. As per a study published in 2019 in the International Journal of Science, Environment, and Technology, the incidence of osteoarthritis was found to be more common among the 5-10 years old dog population. The study also reported that male dogs are more prone to arthritis compared to female dogs.

The COVID-19 pandemic created barriers and challenges in the global companion animal health industry that include decreased marketing and sales activities, low veterinary clinic admission, cancellation of routine pet check-ups, and a low number of arthritis surgery performed in veterinary hospitals. However, the governments and veterinary organizations of various countries implemented strategies and safety measures to resume veterinary practices during the pandemic. According to the American Veterinary Medical Association, telemedicine services were widely incorporated in veterinary clinics and hospitals to curb the impact of lockdowns.

The increasing pet care expenditure in both developing and developed economies is a significant opportunity considered for market growth. According to the American Kennel Club (AKC), pet owners in the U.S. were seen to spend more money on their pet’s wellness and related healthcare products. The American Pet Products Association reported that the overall pet industry sale exceeded USD 100 billion by the end of 2020. The AKC also stated that online veterinary product shopping increased by 86% after the emergence of the pandemic. The trend of owning popular breeds of dogs also enhanced the required routine veterinary care services among them. These factors are expected to boost the growth of the market.

Scope of The Report

Animal Type Insights

The dogs' segment dominated the global market with a share of over 60.04% in 2021. This is due to the rising adoption rates of dogs and the high disease prevalence that was seen among them. The growing population rate of dogs in every region is further boosting the growth of the market. According to the American Veterinary Medical Association, 45% of American households owned dogs in 2020. Similarly, as per the European Pet Food Industry, nearly 88 million households in Europe owned a pet, and the dog population rate in the region was estimated to be 90 million in 2020. In addition, the COVID-19 pandemic has encouraged most people in the world to adopt companion animals for psychological comfort.

The cats' segment is anticipated to expand at a CAGR of 7.48% during the forecast period owing to the increasing awareness among pet parents concerning symptoms of arthritis in their cats. The growing prevalence of osteoarthritis in the cat population is another factor that is boosting the growth of the segment. For instance, according to International Cat Care (ICC), nearly 90% of cats regardless of age suffer from arthritis. The larger breeds are more prevalent to have osteoarthritis. However, due to the natural ability of cats to hide pain owing to their survival instinct, pet owners miss the subtle symptoms shown by their cats during early-stage of arthritis. Such factors might hamper timely diagnosis.

Indication Insights

The osteoarthritis segment dominated the market in 2021 with a revenue share of over 75.06%. This is owing to the large number of companion animals diagnosed with osteoarthritis. According to the American College of Veterinary Surgeons, nearly a quarter of the dog population in the U.S. is prone to developing osteoarthritis. This condition is also seen among cats causing clinical signs such as weight loss, depression, and inability to jump or move actively. For instance, in January 2021, the Veterinary Ireland Journal stated that 40% of every cat shows the aforementioned signs, wherein 90% of older cats develop osteoarthritis.

The other arthritis segment is expected to grow significantly during the forecast period. It includes rheumatoid, septic, and poly arthritis conditions. Rheumatoid arthritis in dogs is chronic leading to severe pain and inflammation in joints. It is less common compared to osteoarthritis, but still significantly affects small cats and dogs. In dogs, it can be diagnosed using a canine rheumatoid factor immunologic test in veterinary hospitals or clinics. Research studies indicated that corticosteroids, cyclosporine, and NSAIDs are the best treatments for rheumatoid arthritis in companion animals.

Treatment Insights

The medication segment held the largest revenue share of over 55.05% in 2021. This is owing to a large number of product launches by veterinary pharmaceutical companies. The NSAIDs, opioids, steroids, stem cells, antibodies, and others are available medication drugs for arthritis in companion animals. The rising risk factors such as obesity, age, and nutritional impairments among pets are increasing the prevalence of arthritis in them. It thereby enhances the awareness among pet owners to start timely treatments for their pets. Supplements are initially prescribed by veterinarians when the symptoms of arthritis are less obvious. This factor increases the demand for supplements among pet owners.

The other treatments such as rehabilitation, lifestyle management, and novel medications are significantly evolving to improve the quality of life for companion animals associated with arthritis. The treatments such as surgery are considered when the medication fails to manage the arthritis condition in companion animals. Most common surgical procedures include joint replacement, joint fusion, and surgical removal of the affected joint. Arthroscopy is a minimally invasive surgical approach that reduces postoperative pain in dogs and cats. Other non-medication treatment options such as weight management, environmental modifications, and physical rehabilitation are also recommended by veterinarians.

Distribution Channel Insights

The veterinary hospitals and clinics segment held the largest revenue share of 30.04% in 2021. This is owing to a growing number of veterinary hospitals and clinics globally with advanced infrastructures. The veterinary clinics and hospitals are very crucial for pet healthcare as they help pet owners understand the proper dosage of arthritis medicine with timely diagnosis. The growing number of veterinary professionals is another factor driving the segment. According to the Federation of Veterinarians of Europe, the number of veterinarians was approximately 263 million in Europe in 2019.

The other distribution channels such as retail pharmacies, online stores, and research institutes are widely contributing to the growth of the market. With an increased number of households owning companion animals, their demand for convenient access to pet arthritis supplements and NSAIDs is increasing. There are various brands of oral supplements, NSAIDs, opioids, and essential oils available in retail vet pharmacies for arthritis application in companion animals. The online sales of pet arthritic products have grown widely during the COVID-19 pandemic. E-commerce or online stores have become a convenient and easily accessible platform for pet medication products.

Regional Insights

North America held the largest revenue share of more than 30.1% in 2021. This is due to the significant presence of key players, the adoption of various strategies initiated by key companies to increase market penetration, rising treatment availability, rising diagnostic rates, and increasing pet population and expenditure. The growing number of veterinary clinics with licensed and trained veterinarians in the countries is another factor expected to boost the growth of the market. According to the AVMA, in 2020, nearly 118,624 licensed veterinarians were estimated in the U.S., which majorly catered to companion animal patients

The European region held the second-largest revenue share in 2021. This is owing to the presence of major players such as Boehringer Ingelheim International GmbH in the European countries. The Asia Pacific region is estimated to expand at a CAGR of 8.33% in the forecast period. This is attributed to the rising animal healthcare expenditure and disposable income in key markets and increasing awareness about the disease in developing countries. The growing demand for the proper and timely diagnosis of companion animal arthritis in developing countries like India is further boosting the growth of the market.

Key Players

• Zoetis
• Virbac
• Elanco
• Boehringer Ingelheim International GmbH
• Ceva
• Dechra Pharmaceuticals PLC.
• Vetoquinol
• NexGen Pharmaceuticals
• Norbrook
• Eltech K-Laser s.r.l.

Market Segmentation

• By Animal Type Outlook

• Dogs
• Cats
• Others
• By Indication Outlook
• Osteoarthritis
• Other Arthritis
• By Treatment Outlook  
• Medication

• NSAIDs
• Monoclonal Antibodies
• Others Medications
• Supplements
• Other Treatment
• By Distribution Channel Outlook
• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Online Stores
• Others
• By Regional Outlook
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• MEA
• South Africa
• Saudi Arabia